China has banned an unproven Alzheimer’s operation and detained its inventor, but international clinical trials of dcLVA are still going ahead—why?

The inventor of an unusual surgical treatment for Alzheimer’s disease is languishing in Chinese detention while his idea gains traction overseas. <b>Felicity Nelson</b> reports

Authors

Publication Details

Journal
BMJ
Published
2026-07-24
DOI
https://doi.org/10.1136/bmj-2026-100302
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

China has banned an unproven Alzheimer’s operation and detained its inventor, but international clinical trials of dcLVA are still going ahead—why?

Felicity Nelson
BMJ
Biomedical Ethics and Regulation
article

China has banned an unproven Alzheimer’s operation and detained its inventor, but international clinical trials of dcLVA are still going ahead—why?

Felicity Nelson
article en

Abstract

The inventor of an unusual surgical treatment for Alzheimer’s disease is languishing in Chinese detention while his idea gains traction overseas. <b>Felicity Nelson</b> reports

BMJVol. 394
Openalex Percentile: Top 9%
Biomedical Ethics and Regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

China has banned an unproven Alzheimer’s operation and detained its inventor, but international clinical trials of dcLVA are still going ahead—why? — Felicity Nelson · BMJ (2026) | TGRS Research Map | TGRS